Glenmark Life Sciences Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹539.73Cr |
Net Profits | ₹97.94Cr |
Net Profit Margins | 18.15% |
Highlights
Revenue:
Glenmark Life Sciences Ltd’s revenue fell -13.53% since last year same period to ₹539.73Cr in the Q4 2023-2024. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -6.05% fall in its revenue since last 3-months.
Net Profits:
Glenmark Life Sciences Ltd’s net profit fell -33.08% since last year same period to ₹97.94Cr in the Q4 2023-2024. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -17.54% fall in its net profits since last 3-months.
Net Profit Margins:
Glenmark Life Sciences Ltd’s net profit margin fell -22.61% since last year same period to 18.15% in the Q4 2023-2024. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated -12.23% fall in its net profit margins since last 3-months.
